Cbp Antibodies

Santa Cruz Biotechnology features a diverse variety of Cbp Antibodies for research applications. Cbp Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cbp, or CREB-binding protein, plays a crucial role in regulating gene expression by acting as a coactivator for various transcription factors. It is involved in numerous cellular processes, including cell growth, differentiation, and apoptosis, making it a significant target for understanding various diseases, including cancer. The study of Cbp is essential for elucidating the molecular mechanisms underlying these processes and developing potential therapeutic strategies. Cbp research has revealed important insights into transcriptional regulation and cellular signaling pathways. Understanding Cbp function has contributed significantly to knowledge about gene expression control and cellular development. Ongoing research with Cbp continues to uncover new aspects of cellular regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Cbp's role in health and disease.